Live Updates for Wednesday, May 6  By Investing.com

© Shutterstock

Rolling updates on the latest developments and headlines from around the world on the Covid-19 pandemic.

By Gina Lee and Peter Nurse

(10:40 PM ET) The White House mulls disbanding Presidential COVID-19 task force

Vice President Mike Pence said the White House is discussing whether to disband the president’s COVID-19 task force, possibly as soon as May 25.

The move comes as Pence said that the task force accomplished its goal of containing the virus as the outbreak in the U.S. slows and some states reopen after weeks-long lockdowns.

(10:37 PM ET) Gilead to Expand Remdesivir Production

Gilead Sciences (NASDAQ:) is looking to expand manufacturing of its Covid-19 treatment remdesivir. The drug received FDA emergency use approval earlier in the week.

Gilead said in a blog post that it is talking with “some of the world’s leading chemical and pharmaceutical manufacturing companies” about their ability to make the drug for Europe, Asia and the developing world through 2022.

It is also in talks with Indian and Pakistani manufacturers about manufacturing and licensing the drug for developing markets.

(10:34 PM ET) Argentina to get $4 billion Development Bank of Latin America loan

Argentina secured a $4 billion loan from the Development Bank of Latin America, with the funds to be used to tackle the economic impact of the virus. 

DBLA will distribute the funds over four years. 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

You may also like...